相关实验视频
Updated: Jan 23, 2026

09:39
Mapping Dysfunctional Protein-Protein Interactions in Disease
Published on: October 24, 2025
706
由FERM域突变引起的FRMD3的结构性不稳定会通过寡头细胞功能障碍引起低髓化疾病
Diksha1, Abhishek Kumar2, Smita Saha3
1All India Institute of Medical Sciences, Rishikesh 249203, India.
ACS chemical neuroscience
|January 21, 2026
概括
一种新型的FRMD3基因变异通过破坏蛋白质的稳定性,导致聚合和小寡腺细胞功能受损,从而导致低髓化疾病. 这一发现将FRMD3确定为神经发育障碍的新候选基因.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 发育神经科学的发展神经科学.
背景情况:
- 低髓化疾病是罕见的神经发育障碍,由于遗传因素影响髓的形成或维持.
- 确定这些疾病的遗传基础对于理解疾病机制和开发疗法至关重要.
研究的目的:
- 为了研究FRMD3基因中一种新型的同卵性误解变异,与小儿病患者的低髓化疾病相关.
- 阐明FRMD3变种导致神经发育病理的分子机制.
主要方法:
- 基因测序以识别FRMD3变种 (c.898T > C; p.C300R). 基因测序用于识别FRMD3变种 (c.898T > C; p.C300R).
- 分子动力学模拟和生物物理分析,以评估蛋白质结构和稳定性.
- 细胞测定 (包括聚合研究和FRMD3在寡细胞中的救援实验) 来评估蛋白质功能.
- 交互原子和单细胞表达分析,绘制FRMD3的细胞定位和相互作用.
主要成果:
- 鉴定到的FRMD3变体 (p.C300R) 破坏了FERM域的稳定,增加了蛋白质聚合,并在细胞模型中引起错位.
- 突变FRMD3损害了寡头细胞神经元的形成,并且无法恢复髓蛋白表达 (PLP1,MBP).
- FRMD3与膜贩运和脂质处理途径有关,这些途径对于寡头细胞功能至关重要.
结论:
- FRMD3是一种新型的候选基因,用于低髓质化疾病.
- 结构性不稳定性和FRMD3的聚合破坏了寡类细胞的功能,导致髓蛋白表达受损和区域性低髓化.
- 这项研究强调了蛋白质结构完整性在神经发育过程中的关键作用.
相关概念视频
Mutations
94.4K
Overview
94.4K
Mutations
44.0K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.0K
Destabilization of Microtubules
3.5K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.5K
Conservation of Protein Domains Over Different Proteins
14.1K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.1K
Drugs that Destabilize Microtubules
3.7K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.7K
Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K

